121 related articles for article (PubMed ID: 28631213)
1. The constitutive protease release by primary human acute myeloid leukemia cells.
Honnemyr M; Bruserud Ø; Brenner AK
J Cancer Res Clin Oncol; 2017 Oct; 143(10):1985-1998. PubMed ID: 28631213
[TBL] [Abstract][Full Text] [Related]
2. Patients with acute myeloid leukemia can be subclassified based on the constitutive cytokine release of the leukemic cells; the possible clinical relevance and the importance of cellular iron metabolism.
Brenner AK; Tvedt TH; Nepstad I; Rye KP; Hagen KM; Reikvam H; Bruserud Ø
Expert Opin Ther Targets; 2017 Apr; 21(4):357-369. PubMed ID: 28281897
[TBL] [Abstract][Full Text] [Related]
3. CDC25A governs proliferation and differentiation of FLT3-ITD acute myeloid leukemia.
Bertoli S; Boutzen H; David L; Larrue C; Vergez F; Fernandez-Vidal A; Yuan L; Hospital MA; Tamburini J; Demur C; Delabesse E; Saland E; Sarry JE; Galcera MO; Mansat-De Mas V; Didier C; Dozier C; Récher C; Manenti S
Oncotarget; 2015 Nov; 6(35):38061-78. PubMed ID: 26515730
[TBL] [Abstract][Full Text] [Related]
4. Primary human acute myelogenous leukemia cells release matrix metalloproteases and their inhibitors: release profile and pharmacological modulation.
Reikvam H; Hatfield KJ; Oyan AM; Kalland KH; Kittang AO; Bruserud O
Eur J Haematol; 2010 Mar; 84(3):239-51. PubMed ID: 19922462
[TBL] [Abstract][Full Text] [Related]
5. Identification of a subset of patients with acute myeloid leukemia characterized by long-term in vitro proliferation and altered cell cycle regulation of the leukemic cells.
Hatfield KJ; Reikvam H; Bruserud Ø
Expert Opin Ther Targets; 2014 Nov; 18(11):1237-51. PubMed ID: 25200484
[TBL] [Abstract][Full Text] [Related]
6. Leptin in human acute myelogenous leukemia: studies of in vivo levels and in vitro effects on native functional leukemia blasts.
Bruserud Ø; Huang TS; Glenjen N; Gjertsen BT; Foss B
Haematologica; 2002 Jun; 87(6):584-95. PubMed ID: 12031914
[TBL] [Abstract][Full Text] [Related]
7. In vitro effects of native human acute myelogenous leukemia blasts on fibroblasts and osteoblasts.
Glenjen N; Ersvaer E; Ryningen A; Bruserud Ø
Int J Cancer; 2004 Oct; 111(6):858-67. PubMed ID: 15300797
[TBL] [Abstract][Full Text] [Related]
8. CD34 expression in native human acute myelogenous leukemia blasts: differences in CD34 membrane molecule expression are associated with different gene expression profiles.
Oyan AM; Bø TH; Jonassen I; Ulvestad E; Gjertsen BT; Kalland KH; Bruserud O
Cytometry B Clin Cytom; 2005 Mar; 64(1):18-27. PubMed ID: 15668952
[TBL] [Abstract][Full Text] [Related]
9. MiR-181 family: regulators of myeloid differentiation and acute myeloid leukemia as well as potential therapeutic targets.
Su R; Lin HS; Zhang XH; Yin XL; Ning HM; Liu B; Zhai PF; Gong JN; Shen C; Song L; Chen J; Wang F; Zhao HL; Ma YN; Yu J; Zhang JW
Oncogene; 2015 Jun; 34(25):3226-39. PubMed ID: 25174404
[TBL] [Abstract][Full Text] [Related]
10. Hypoxia increases HIF-1α expression and constitutive cytokine release by primary human acute myeloid leukaemia cells.
Hatfield KJ; Bedringsaas SL; Ryningen A; Gjertsen BT; Bruserud O
Eur Cytokine Netw; 2010 Sep; 21(3):154-64. PubMed ID: 20729179
[TBL] [Abstract][Full Text] [Related]
11. CDC25 Inhibition in Acute Myeloid Leukemia-A Study of Patient Heterogeneity and the Effects of Different Inhibitors.
Brenner AK; Reikvam H; Rye KP; Hagen KM; Lavecchia A; Bruserud Ø
Molecules; 2017 Mar; 22(3):. PubMed ID: 28287460
[TBL] [Abstract][Full Text] [Related]
12. Expression profiling of cytogenetically normal acute myeloid leukemia identifies microRNAs that target genes involved in monocytic differentiation.
Lutherborrow M; Bryant A; Jayaswal V; Agapiou D; Palma C; Yang YH; Ma DD
Am J Hematol; 2011 Jan; 86(1):2-11. PubMed ID: 20981674
[TBL] [Abstract][Full Text] [Related]
13. MicroRNA-9 promotes proliferation of leukemia cells in adult CD34-positive acute myeloid leukemia with normal karyotype by downregulation of Hes1.
Tian C; You MJ; Yu Y; Zhu L; Zheng G; Zhang Y
Tumour Biol; 2016 Jun; 37(6):7461-71. PubMed ID: 26678889
[TBL] [Abstract][Full Text] [Related]
14. Proteomic Profiling of Primary Human Acute Myeloid Leukemia Cells Does Not Reflect Their Constitutive Release of Soluble Mediators.
Aasebø E; Hernandez-Valladares M; Selheim F; Berven FS; Brenner AK; Bruserud Ø
Proteomes; 2018 Dec; 7(1):. PubMed ID: 30577422
[TBL] [Abstract][Full Text] [Related]
15. Tumor SHB gene expression affects disease characteristics in human acute myeloid leukemia.
Jamalpour M; Li X; Cavelier L; Gustafsson K; Mostoslavsky G; Höglund M; Welsh M
Tumour Biol; 2017 Oct; 39(10):1010428317720643. PubMed ID: 28982308
[TBL] [Abstract][Full Text] [Related]
16. Release of angiopoietin-1 by primary human acute myelogenous leukemia cells is associated with mutations of nucleophosmin, increased by bone marrow stromal cells and possibly antagonized by high systemic angiopoietin-2 levels.
Hatfield KJ; Hovland R; Øyan AM; Kalland KH; Ryningen A; Gjertsen BT; Bruserud Ø
Leukemia; 2008 Feb; 22(2):287-93. PubMed ID: 17943167
[TBL] [Abstract][Full Text] [Related]
17. High Constitutive Cytokine Release by Primary Human Acute Myeloid Leukemia Cells Is Associated with a Specific Intercellular Communication Phenotype.
Reikvam H; Aasebø E; Brenner AK; Bartaula-Brevik S; Grønningsæter IS; Forthun RB; Hovland R; Bruserud Ø
J Clin Med; 2019 Jul; 8(7):. PubMed ID: 31277464
[TBL] [Abstract][Full Text] [Related]
18. Effects of vascular endothelial growth factor on acute myelogenous leukemia blasts.
Foss B; Mentzoni L; Bruserud O
J Hematother Stem Cell Res; 2001 Feb; 10(1):81-93. PubMed ID: 11276362
[TBL] [Abstract][Full Text] [Related]
19. Soluble mediators released by acute myeloid leukemia cells increase capillary-like networks.
Hatfield KJ; Evensen L; Reikvam H; Lorens JB; Bruserud Ø
Eur J Haematol; 2012 Dec; 89(6):478-90. PubMed ID: 23046151
[TBL] [Abstract][Full Text] [Related]
20. High expression of urokinase plasminogen activator receptor (UPA-R) in acute myeloid leukemia (AML) is associated with worse prognosis.
Graf M; Reif S; Hecht K; Pelka-Fleischer R; Pfister K; Schmetzer H
Am J Hematol; 2005 May; 79(1):26-35. PubMed ID: 15849776
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
